{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:39:38Z","timestamp":1794667178028,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2022-YXZX-MY-02"],"award-info":[{"award-number":["2022-YXZX-MY-02"]}]},{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2021-LCYJ-PY-37"],"award-info":[{"award-number":["2021-LCYJ-PY-37"]}]},{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2021-LCYJ-DBZ-02"],"award-info":[{"award-number":["2021-LCYJ-DBZ-02"]}]},{"name":"Nanjing Health Technology Development Fund Project","award":["ZKX21016"],"award-info":[{"award-number":["ZKX21016"]}]},{"name":"Jiangsu Medical Innovation Team (Leading Talents) Project","award":["CXTDA2017041"],"award-info":[{"award-number":["CXTDA2017041"]}]},{"name":"Youth Development Program from Nanjing Drum Tower Hospital","award":["2022-JCYJ-QP-04"],"award-info":[{"award-number":["2022-JCYJ-QP-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03915-3","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:48:41Z","timestamp":1762166921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors of incident lung diseases and the impact of DMARDs in rheumatoid arthritis patients: a longitudinal study"],"prefix":"10.1186","volume":"25","author":[{"given":"Guangcai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8563-2036","authenticated-orcid":false,"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"3915_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8.","journal-title":"Lancet"},{"key":"3915_CR2","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1183\/09031936.00152607","volume":"33","author":"KM Antoniou","year":"2009","unstructured":"Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J. 2009;33:882\u201396. https:\/\/doi.org\/10.1183\/09031936.00152607.","journal-title":"Eur Respir J"},{"key":"3915_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/09059180.00008014","volume":"24","author":"M Shaw","year":"2015","unstructured":"Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 2015;24:1\u201316. https:\/\/doi.org\/10.1183\/09059180.00008014.","journal-title":"Eur Respir Rev"},{"key":"3915_CR4","doi-asserted-by":"publisher","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","volume":"30","author":"S Kadura","year":"2021","unstructured":"Kadura S, Raghu G. Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management. Eur Respir Rev. 2021;30:210011. https:\/\/doi.org\/10.1183\/16000617.0011-2021.","journal-title":"Eur Respir Rev"},{"key":"3915_CR5","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.ejrad.2015.07.008","volume":"84","author":"T Chansakul","year":"2015","unstructured":"Chansakul T, Dellaripa PF, Doyle TJ, Madan R. Intra-thoracic rheumatoid arthritis: imaging spectrum of typical findings and treatment related complications. Eur J Radiol. 2015;84:1981\u201391. https:\/\/doi.org\/10.1016\/j.ejrad.2015.07.008.","journal-title":"Eur J Radiol"},{"key":"3915_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.rdc.2014.12.004","volume":"41","author":"ZX Yunt","year":"2015","unstructured":"Yunt ZX, Solomon JJ. Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am. 2015;41:225\u201336. https:\/\/doi.org\/10.1016\/j.rdc.2014.12.004.","journal-title":"Rheum Dis Clin North Am"},{"key":"3915_CR7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, L\u00f8kke A, Bendstrup E, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis. 2017;76:1700\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211138.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/acr.22752","volume":"68","author":"JA Sparks","year":"2016","unstructured":"Sparks JA, Chang S, Liao KP, Lu B, Fine AR, Solomon DH, et al. Rheumatoid arthritis and mortality among women during 36 years of prospective follow-up: results from the nurses\u2019 health study. Arthritis Care Res. 2016;68:753\u201362. https:\/\/doi.org\/10.1002\/acr.22752.","journal-title":"Arthritis Care Res"},{"key":"3915_CR9","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1093\/rheumatology\/keac208","volume":"61","author":"R Brooks","year":"2022","unstructured":"Brooks R, Baker JF, Yang Y, Roul P, Kerr GS, Reimold AM, et al. The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease. Rheumatology. 2022;61:4667\u201377. https:\/\/doi.org\/10.1093\/rheumatology\/keac208.","journal-title":"Rheumatology"},{"key":"3915_CR10","doi-asserted-by":"publisher","first-page":"e001817","DOI":"10.1136\/bmjresp-2023-001817","volume":"11","author":"C Yu","year":"2024","unstructured":"Yu C, Zhang Y, Jin S, Wang Y, Wang Q, Li M, et al. Risk factors for incidence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis. BMJ Open Respir Res. 2024;11:e001817. https:\/\/doi.org\/10.1136\/bmjresp-2023-001817.","journal-title":"BMJ Open Respir Res"},{"key":"3915_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/art.40574","volume":"70","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V. The lung in rheumatoid arthritis: focus on interstitial lung disease. Arthritis Rheumatol. 2018;70:1544\u201354. https:\/\/doi.org\/10.1002\/art.40574.","journal-title":"Arthritis Rheumatol"},{"key":"3915_CR12","doi-asserted-by":"publisher","first-page":"11678","DOI":"10.1038\/s41598-023-37452-y","volume":"13","author":"J Zhuo","year":"2023","unstructured":"Zhuo J, Lama S, Knapp K, Gutierrez C, Lovett K, Thai S, et al. Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the jointman database. Sci Rep. 2023;13:11678. https:\/\/doi.org\/10.1038\/s41598-023-37452-y.","journal-title":"Sci Rep"},{"key":"3915_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","volume":"36","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li H, Wu N, Dong X, Zheng Y. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol. 2017;36:817\u201323. https:\/\/doi.org\/10.1007\/s10067-017-3561-5.","journal-title":"Clin Rheumatol"},{"key":"3915_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3899\/jrheum.200863","volume":"48","author":"VL Kronzer","year":"2021","unstructured":"Kronzer VL, Huang W, Dellaripa PF, Huang S, Feathers V, Lu B, et al. Lifestyle and clinical risk factors for incident rheumatoid Arthritis-associated interstitial lung disease. J Rheumatol. 2021;48:656\u201363. https:\/\/doi.org\/10.3899\/jrheum.200863.","journal-title":"J Rheumatol"},{"key":"3915_CR15","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.40904","volume":"71","author":"JA Sparks","year":"2019","unstructured":"Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM, et al. Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis\u2013associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol. 2019;71:1472\u201382. https:\/\/doi.org\/10.1002\/art.40904.","journal-title":"Arthritis Rheumatol"},{"key":"3915_CR16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population\u2010based study. Arthritis Rheum. 2010;62:1583\u201391. https:\/\/doi.org\/10.1002\/art.27405.","journal-title":"Arthritis Rheum"},{"key":"3915_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2332406","volume":"56","author":"H-F Wang","year":"2024","unstructured":"Wang H-F, Wang Y-Y, Li Z-Y, He P-J, Liu S, Li Q-S. The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Ann Med. 2024;56: 2332406. https:\/\/doi.org\/10.1080\/07853890.2024.2332406.","journal-title":"Ann Med"},{"key":"3915_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","volume":"66","author":"R Conway","year":"2014","unstructured":"Conway R, Low C, Coughlan RJ, O\u2019Donnell MJ, Carey JJ. Methotrexate and lung disease in rheumatoid arthritis: A Meta-Analysis of randomized controlled trials: risk of lung disease in RA patients treated with MTX. Arthritis Rheumatol. 2014;66:803\u201312. https:\/\/doi.org\/10.1002\/art.38322.","journal-title":"Arthritis Rheumatol"},{"key":"3915_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","volume":"15","author":"S Imokawa","year":"2000","unstructured":"Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J. 2000;15:373. https:\/\/doi.org\/10.1034\/j.1399-3003.2000.15b25.x.","journal-title":"Eur Respir J"},{"key":"3915_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7326\/M19-3369","volume":"172","author":"DH Solomon","year":"2020","unstructured":"Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, et al. Adverse effects of low-dose methotrexate: a randomized trial. Ann Intern Med. 2020;172:369. https:\/\/doi.org\/10.7326\/M19-3369.","journal-title":"Ann Intern Med"},{"key":"3915_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/art.21806","volume":"54","author":"S Suissa","year":"2006","unstructured":"Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum. 2006;54:1435\u20139. https:\/\/doi.org\/10.1002\/art.21806.","journal-title":"Arthritis Rheum"},{"key":"3915_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/rheumatology\/kep052","volume":"48","author":"T Sawada","year":"2009","unstructured":"Sawada T, Inokuma S, Sato T, Otsuka T, Saeki Y, Takeuchi T, et al. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology. 2009;48:1069\u201372. https:\/\/doi.org\/10.1093\/rheumatology\/kep052.","journal-title":"Rheumatology"},{"key":"3915_CR23","doi-asserted-by":"publisher","first-page":"h1269","DOI":"10.1136\/bmj.h1269","volume":"350","author":"R Conway","year":"2015","unstructured":"Conway R, Low C, Coughlan RJ, O\u2019Donnell MJ, Carey JJ. Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials. BMJ. 2015;350:h1269\u20131269. https:\/\/doi.org\/10.1136\/bmj.h1269.","journal-title":"BMJ"},{"key":"3915_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/rheumatology\/keaa327","volume":"60","author":"EH Ibfelt","year":"2021","unstructured":"Ibfelt EH, Jacobsen RK, Kopp TI, Cordtz RL, Jakobsen AS, Seersholm N, et al. Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study. Rheumatology. 2021;60:346\u201352. https:\/\/doi.org\/10.1093\/rheumatology\/keaa327.","journal-title":"Rheumatology"},{"key":"3915_CR25","doi-asserted-by":"publisher","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","volume":"9","author":"P Kiely","year":"2019","unstructured":"Kiely P, Busby AD, Nikiphorou E, Sullivan K, Walsh DA, Creamer P, et al. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open. 2019;9:e028466. https:\/\/doi.org\/10.1136\/bmjopen-2018-028466.","journal-title":"BMJ Open"},{"key":"3915_CR26","doi-asserted-by":"publisher","first-page":"2000337","DOI":"10.1183\/13993003.00337-2020","volume":"57","author":"P-A Juge","year":"2021","unstructured":"Juge P-A, Lee JS, Lau J, Kawano-Dourado L, Rojas Serrano J, Sebastiani M, et al. Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J. 2021;57:2000337. https:\/\/doi.org\/10.1183\/13993003.00337-2020.","journal-title":"Eur Respir J"},{"key":"3915_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3899\/jrheum.150674","volume":"43","author":"R Conway","year":"2016","unstructured":"Conway R, Low C, Coughlan RJ, O\u2019Donnell MJ, Carey JJ. Leflunomide use and risk of lung disease in rheumatoid arthritis: a systematic literature review and metaanalysis of randomized controlled trials. J Rheumatol. 2016;43:855\u201360. https:\/\/doi.org\/10.3899\/jrheum.150674.","journal-title":"J Rheumatol"},{"key":"3915_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152004","volume":"55","author":"N Chen","year":"2022","unstructured":"Chen N, Diao C-Y, Gao J, Zhao D-B. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: clinical features, biomarkers, and treatment options. Semin Arthritis Rheum. 2022;55: 152004. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152004.","journal-title":"Semin Arthritis Rheum"},{"key":"3915_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rhuem. 1988;31:315\u201324. https:\/\/doi.org\/10.1002\/art.1780310302.","journal-title":"Arthr Rhuem"},{"key":"3915_CR30","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138. https:\/\/doi.org\/10.1136\/ard.2010.138461.","journal-title":"Ann Rheum Dis"},{"key":"3915_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"3915_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.semarthrit.2020.06.005","volume":"50","author":"C-Y Lin","year":"2020","unstructured":"Lin C-Y, Ko C-H, Hsu C-Y, Chen H-A. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: a national cohort study in Taiwan. Semin Arthritis Rheum. 2020;50:957\u201362. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.005.","journal-title":"Semin Arthritis Rheum"},{"key":"3915_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"MLL Prevoo","year":"1995","unstructured":"Prevoo MLL, Van \u2019T, Hof MA, Kuper HH, Van Leeuwen MA, Van De Putte LBA, Van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis: MODIFIED DISEASE ACTIVITY SCORE. Arthr Rhuem. 1995;38:44\u20138. https:\/\/doi.org\/10.1002\/art.1780380107.","journal-title":"Arthr Rhuem"},{"key":"3915_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acr.22456","volume":"67","author":"BR England","year":"2015","unstructured":"England BR, Sayles H, Mikuls TR, Johnson DS, Michaud K. Validation of the rheumatic disease comorbidity index: RDCI validation. Arthritis Care Res. 2015;67:865\u201372. https:\/\/doi.org\/10.1002\/acr.22456.","journal-title":"Arthritis Care Res"},{"key":"3915_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13075-015-0835-7","volume":"17","author":"JR Curtis","year":"2015","unstructured":"Curtis JR, Sarsour K, Napalkov P, Costa LA, Schulman KL. Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor \u03b1 agents, a retrospective cohort study. Arthritis Res Ther. 2015;17:319. https:\/\/doi.org\/10.1186\/s13075-015-0835-7.","journal-title":"Arthritis Res Ther"},{"key":"3915_CR36","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/art.42860","volume":"76","author":"SR Johnson","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB, Chung JH, Danoff SK, George MD, et al. 2023 American college of rheumatology (ACR)\/American college of chest physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Rheumatol. 2024;76:1201\u201313. https:\/\/doi.org\/10.1002\/art.42860.","journal-title":"Arthritis Rheumatol"},{"key":"3915_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.12659\/MSM.890880","volume":"21","author":"C-G Du","year":"2015","unstructured":"Du C-G. A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients. Med Sci Monit. 2015;21:708\u201315. https:\/\/doi.org\/10.12659\/MSM.890880.","journal-title":"Med Sci Monit"},{"key":"3915_CR38","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/kez177","volume":"58","author":"AC Duarte","year":"2019","unstructured":"Duarte AC, Porter JC, Leandro MJ. The lung in a cohort of rheumatoid arthritis patients\u2014an overview of different types of involvement and treatment. Rheumatology. 2019;58:2031\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kez177.","journal-title":"Rheumatology"},{"key":"3915_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4103\/atm.ATM_392_16","volume":"12","author":"OSB Alamoudi","year":"2017","unstructured":"Alamoudi OSB, Attar S. Pleuropulmonary manifestation in patients with rheumatoid arthritis in Saudi Arabia. Ann Thorac Med. 2017;12:266. https:\/\/doi.org\/10.4103\/atm.ATM_392_16.","journal-title":"Ann Thorac Med"},{"key":"3915_CR40","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semarthrit.2020.08.015","volume":"50","author":"S Huang","year":"2020","unstructured":"Huang S, Doyle TJ, Hammer MM, Byrne SC, Huang W, Marshall AA, et al. Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: prevalence, risk factors, and impact on mortality. Semin Arthritis Rheum. 2020;50:1216\u201325. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.08.015.","journal-title":"Semin Arthritis Rheum"},{"key":"3915_CR41","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/rheumatology\/kez409","volume":"59","author":"E Nikiphorou","year":"2020","unstructured":"Nikiphorou E, de Lusignan S, Mallen C, Roberts J, Khavandi K, Bedarida G, et al. Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study. Rheumatology. 2020;59:1296\u2013305. https:\/\/doi.org\/10.1093\/rheumatology\/kez409.","journal-title":"Rheumatology"},{"key":"3915_CR42","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1440-1843.2010.01774.x","volume":"15","author":"TJ Huie","year":"2010","unstructured":"Huie TJ, Olson AL, Cosgrove GP, Janssen WJ, Lara AR, Lynch DA, et al. A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes: acute decline in fibrotic lung disease. Respirology. 2010;15:909\u201317. https:\/\/doi.org\/10.1111\/j.1440-1843.2010.01774.x.","journal-title":"Respirology"},{"key":"3915_CR43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/17476348.2019.1632196","volume":"13","author":"GA Margaritopoulos","year":"2019","unstructured":"Margaritopoulos GA, Kokosi MA, Wells AU. Diagnosing complications and co-morbidities of fibrotic interstitial lung disease. Expert Rev Respir Med. 2019;13:645\u201358. https:\/\/doi.org\/10.1080\/17476348.2019.1632196.","journal-title":"Expert Rev Respir Med"},{"key":"3915_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/03009742.2017.1324909","volume":"47","author":"H Alani","year":"2018","unstructured":"Alani H, Henty J, Thompson N, Jury E, Ciurtin C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in sj\u00f6gren\u2019s syndrome (secondary sj\u00f6gren\u2019s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018;47:141\u201354. https:\/\/doi.org\/10.1080\/03009742.2017.1324909.","journal-title":"Scand J Rheumatol"},{"key":"3915_CR45","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/rheumatology\/keu400","volume":"54","author":"LE Brown","year":"2015","unstructured":"Brown LE, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Liao KP. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology. 2015;54:816\u201320. https:\/\/doi.org\/10.1093\/rheumatology\/keu400.","journal-title":"Rheumatology"},{"key":"3915_CR46","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s10067-020-05004-8","volume":"39","author":"LR Harrold","year":"2020","unstructured":"Harrold LR, Shan Y, Rebello S, Kramer N, Connolly SE, Alemao E, et al. Prevalence of sj\u00f6gren\u2019s syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry. Clin Rheumatol. 2020;39:1899\u2013905. https:\/\/doi.org\/10.1007\/s10067-020-05004-8.","journal-title":"Clin Rheumatol"},{"key":"3915_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-0039-1685537","volume":"40","author":"JR Hannah","year":"2019","unstructured":"Hannah JR, D\u2019Cruz DP. Pulmonary complications of systemic lupus erythematosus. Semin Respir Crit Care Med. 2019;40:227\u201334. https:\/\/doi.org\/10.1055\/s-0039-1685537.","journal-title":"Semin Respir Crit Care Med"},{"key":"3915_CR48","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3899\/jrheum.211242","volume":"49","author":"G McDermott","year":"2022","unstructured":"McDermott G, Gill R, Gagne S, Byrne S, Huang W, Wang X, et al. Demographic, lifestyle, and serologic risk factors for rheumatoid arthritis (RA)\u2013associated bronchiectasis: role of RA-related autoantibodies. J Rheumatol. 2022;49:672\u20139. https:\/\/doi.org\/10.3899\/jrheum.211242.","journal-title":"J Rheumatol"},{"key":"3915_CR49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1513\/AnnalsATS.202006-590OC","volume":"18","author":"JG Natalini","year":"2021","unstructured":"Natalini JG, Baker JF, Singh N, Mahajan TD, Roul P, Thiele GM, et al. Autoantibody seropositivity and risk for interstitial lung disease in a prospective male-predominant rheumatoid arthritis cohort of U.S. veterans. Ann ATS. 2021;18:598\u2013605. https:\/\/doi.org\/10.1513\/AnnalsATS.202006-590OC.","journal-title":"Ann ATS"},{"key":"3915_CR50","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1093\/rheumatology\/keac651","volume":"62","author":"J-W Kim","year":"2023","unstructured":"Kim J-W, Chung SW, Pyo JY, Chang SH, Kim MU, Park CH, et al. Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease. Rheumatology. 2023;62:2377\u201385. https:\/\/doi.org\/10.1093\/rheumatology\/keac651.","journal-title":"Rheumatology"},{"key":"3915_CR51","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/imj.14670","volume":"50","author":"A Manfredi","year":"2020","unstructured":"Manfredi A, Cassone G, Furini F, Gremese E, Venerito V, Atzeni F, et al. Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study. Intern Med J. 2020;50:1085\u201390. https:\/\/doi.org\/10.1111\/imj.14670.","journal-title":"Intern Med J"},{"key":"3915_CR52","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/jcm12030957","volume":"12","author":"V Venerito","year":"2023","unstructured":"Venerito V, Manfredi A, Carletto A, Gentileschi S, Atzeni F, Guiducci S, et al. Evolution of rheumatoid-arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a retrospective exploratory study. JCM. 2023;12:957. https:\/\/doi.org\/10.3390\/jcm12030957.","journal-title":"JCM"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03915-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03915-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03915-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:48:42Z","timestamp":1762166922000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03915-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03915-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4589846\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Institutional Review Board of Nanjing Drum Tower Hospital (Approval No. 2023-541-01), with a waiver of written informed consent granted in accordance with institutional guidelines for retrospective research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"504"}}